Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Research Area(s) / Expertise: Job title: Head of the School of Psychology
Prof Jason Halford is Head of the School of Psychology at the University of Leeds, and President of the European Association for the Study of Obesity (EASO). His research has focused on eating behaviour and weight management, and the role of psychological factors in weight gain and weight loss, with a recent focus on stress and coping. View more
ECO 24: EASL-EASD-EASO Practice Guidelines for MAFLD
Author(s): Sven M Francque Added: 2 years ago
ECO 2024 — Prof Sven Francque (University of Antwerp, BE) joins us to talk about the new EASL-EASD-EASO Practice Guidelines for MAFLD.In this interview, Prof Francque highlights some of the unmet needs in people with MAFLD (formerly known as NAFLD). He then summarises the key highlights of the latest guidelines, including guidance on treatment options. He also discusses some of the challenges… View more

Guidelines & Statements

Prevention & Chronic Conditions
Sabine Steiner
Dr Sabine Steiner is a professor for applied vascular research at the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig. Her research areas include epidemiology, restenosis, endovascular interventions, clinical trials, and swine models of vascular disease. View more
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors
Author(s): Christina Magnussen Added: 1 year ago
ACC 2025 - Individual-level data collected across 126 worldwide cohorts show controlling modifiable cardiovascular risk factors can potentially benefit life-years for freedom from CVD and death from any cause.Prof Christina Magnussen (University Heart and Vascular Centre Hamburg, Hamberg, DE) joins us onsite at ACC to discuss modifiable cardiovascular risk factors collected by the Global… View more

Cardiovascular Kidney Metabolic
Study: 6 in 10 US Adults Eligible for CKM Drugs
Added: 4 months ago Source:  Radcliffe CVRM
With the rising prevalence of obesity and associated cardiovascular-kidney-metabolic (CKM) syndrome, indications for novel therapies are expanding. A new study has quantified the proportion of US adults who meet the approved indications for three key classes of CKM medications, revealing a substantial number are eligible for treatment.¹MethodologyThis cross-sectional study analysed data from… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Erin Bohula
Dr Erin Bohula, MD, DPhil is an Associate Physician in Cardiovascular Medicine at Brigham and Women's Hospital, an Instructor of Medicine at Harvard Medical School, and an Investigator at the TIMI Study Group. Dr Bohula research interests include the interplay of obesity, metabolic health and cardiovascular disease, evaluation of novel biomarkers and the application of innovative technologies for… View more
Dr. Midtbø is senior researcher at The centre for research on heart disease in women at the University of Bergen (https://www.uib.no/en/femaleheart) and MD at the Department of Heart Disease, Haukeland University Hospital, Norway. Her research focuses on heart disease in patients with rheumatic and autoimmune diseases, obesity and cardiac disease in women. Dr Helga Midtbø is on the Editorial… View more
Job title: Professor of Medicine and Pharmacology and Chief of the Section of Endocrinology, Diabetes, and Metabolism
AHA 24: 3 Trials That Will Change My Practice
Author(s): Michelle Kittleson Added: 1 year ago
AHA Conference 2024 - In this highlights video from AHA 2024, Dr Michelle Kittleson (Cedars-Sinai California Heart Center, US) offers a concise and insightful summary of the most influential late-breaking trials presented at the conference. Dr Kittleson discusses the pivotal studies poised to impact clinical practice and enhance patient outcomes in heart failure care.Trials covered in detail… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Research Area(s) / Expertise: Job title: Head of Pathology
Prof Carel le Roux isHead of Pathology atUniversity College Dublin, Dublin, IE. He graduated from medical school in Pretoria South Africa, completed his Senior House Officer training at Barts and The London Hospital, his SpR training in metabolic medicine at the Hammersmith Hospitals and his PhD at Imperial College London. Working within the Diabetes Complications Research Centre and the… View more